Browse by topic/sector

64 results found

Results per page:10 20 50

1 - 10 of 64Next

Health and Social Care Procurement (Digital and Data) Baselining - executive summary (2023) This report tests the feasibility of establishing a baseline of health and care procurement spend for digital and data opportunities. Establishing such a baseline will help ensure the accurate evaluat...
Review of the life science and health tech innovation and commercialisation support landscape (2023) This research provides a review of the support ecosystem and the organisations currently providing innovation and commercialisation support to Scottish health innovation life sciences companies (inclu...
Evaluation of the Scottish Co-investment Fund (SCF) and Scottish Venture Fund (SVF) III and IV (2022) The evaluation assesses the performance of the Scottish Co-Investment Fund (SCF) and the Scottish Venture Fund (SVF), covering Phase III and part of Phase IV of the funds’ operation (July 2015 to Marc...
Opportunity for Scottish Pharmaceutical Service Companies in Microbiome Drug Discovery and Development (2022) The microbiome has emerged as a potential untapped therapeutic target in a number of diseases. This work aimed to assess the opportunity for Scottish Pharmaceutical Service companies to provide soluti...
Employee-Owned Business Census 2022 (2022) To undertake a census of all employee-owned businesses (EOB & worker co-operatives) operating in Scotland (as at 5.4.22) to enable policy implementers to track recent developments in the size of the s...
Life Sciences in Scotland Industry Leadership Group Digital & Data Subgroup Opportunities and Priorities – Final Report (2021) The report was commissioned by Scottish Enterprise’s Health for Wealth team on behalf of the Digital and Data subgroup of the Life Sciences Scotland Industry Leadership Group (ILGDD). The work was ove...
Business births, business deaths, and business survival rates analysis (2021) This research provides an overview of trends, taken from Office for National Statistics (ONS) data, of business births, deaths, and survival rates, in Scotland – by local authority, industry and age. ...
Growth businesses in Scotland 2016-20 (2021) This is an update to previous research which considered growth businesses in Scotland from 2011-16. This continues to look further into growth than simply applying the usual ‘high-growth’ definition a...
Epidarex Capital II: Interim Review (2020) In 2013 Scottish Enterprise became a Limited Partner in the Epidarex II Life Sciences Investment Fund. The Fund invests in Life Sciences companies with an emphasis on those spun-out from universities ...
Growth companies in Scotland (2017) This research was designed to identify the nature and extent of growth across the business base in Scotland. It sought to identify the locations in which companies achieve intermittent and sustained g...

Health and Social Care Procurement (Digital and Data) Baselining - executive summary (2023) This report tests the feasibility of establishing a baseline of health and care procurement spend for digital and data opportunities. Establishing such a baseline will help ensure the accurate evaluat...

Review of the life science and health tech innovation and commercialisation support landscape (2023) This research provides a review of the support ecosystem and the organisations currently providing innovation and commercialisation support to Scottish health innovation life sciences companies (inclu...

Evaluation of the Scottish Co-investment Fund (SCF) and Scottish Venture Fund (SVF) III and IV (2022) The evaluation assesses the performance of the Scottish Co-Investment Fund (SCF) and the Scottish Venture Fund (SVF), covering Phase III and part of Phase IV of the funds’ operation (July 2015 to Marc...

Opportunity for Scottish Pharmaceutical Service Companies in Microbiome Drug Discovery and Development (2022) The microbiome has emerged as a potential untapped therapeutic target in a number of diseases. This work aimed to assess the opportunity for Scottish Pharmaceutical Service companies to provide soluti...

Employee-Owned Business Census 2022 (2022) To undertake a census of all employee-owned businesses (EOB & worker co-operatives) operating in Scotland (as at 5.4.22) to enable policy implementers to track recent developments in the size of the s...

Life Sciences in Scotland Industry Leadership Group Digital & Data Subgroup Opportunities and Priorities – Final Report (2021) The report was commissioned by Scottish Enterprise’s Health for Wealth team on behalf of the Digital and Data subgroup of the Life Sciences Scotland Industry Leadership Group (ILGDD). The work was ove...

Business births, business deaths, and business survival rates analysis (2021) This research provides an overview of trends, taken from Office for National Statistics (ONS) data, of business births, deaths, and survival rates, in Scotland – by local authority, industry and age. ...

Growth businesses in Scotland 2016-20 (2021) This is an update to previous research which considered growth businesses in Scotland from 2011-16. This continues to look further into growth than simply applying the usual ‘high-growth’ definition a...

Epidarex Capital II: Interim Review (2020) In 2013 Scottish Enterprise became a Limited Partner in the Epidarex II Life Sciences Investment Fund. The Fund invests in Life Sciences companies with an emphasis on those spun-out from universities ...

Growth companies in Scotland (2017) This research was designed to identify the nature and extent of growth across the business base in Scotland. It sought to identify the locations in which companies achieve intermittent and sustained g...

Browse Navigation